To help drug development sponsors better understand this rapidly growing field, this webinar provides a comprehensive overview of immunotoxicity assessment and its pivotal role in drug safety.
TORONTO (PRWEB) November 03, 2020
Immune system safety assessment has emerged as a significant and indispensable area of the drug preclinical development industry, especially for biologics. To help drug development sponsors better understand this rapidly growing field, this webinar provides a comprehensive overview of immunotoxicity assessment and its pivotal role in drug safety.
Join expert speakers from Covance, Aric Frantz, DVM, PhD, I&I Senior Science Lead and Manager; and Amanda Lucchini, PhD, I&I SD/CS/PI and Manager, in a live webinar on Monday, November 16, 2020 at 10am CST (China) to gain insights into predicting potential immunotoxicity, understanding regulatory guidelines and comparing common investigative approaches.
The speakers will cover core assays, which remain critical for compounds that impact the immune system, as well as discuss recent trends with translational assays, such as cytokine release and receptor occupancy, along with potential areas for advanced development.
For more information, or to register for this event, visit Immunology and Immunotoxicology Endpoints in Early Drug Development.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.